These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31410788)

  • 21. Backbone modifications in oligonucleotides and peptide nucleic acid systems.
    De Mesmaeker A; Altmann KH; Waldner A; Wendeborn S
    Curr Opin Struct Biol; 1995 Jun; 5(3):343-55. PubMed ID: 7583633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, hybridization characteristics, and fluorescence properties of oligonucleotides modified with nucleobase-functionalized locked nucleic acid adenosine and cytidine monomers.
    Kaura M; Kumar P; Hrdlicka PJ
    J Org Chem; 2014 Jul; 79(13):6256-68. PubMed ID: 24933409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the effect of 2'-O-methyl, fluoro hexitol, bicyclo and Morpholino nucleic acid modifications on potency of GalNAc conjugated antisense oligonucleotides in mice.
    Prakash TP; Yu J; Kinberger GA; Low A; Jackson M; Rigo F; Swayze EE; Seth PP
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3774-3779. PubMed ID: 30342955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleic acid aptamers as tools and drugs: recent developments.
    Rimmele M
    Chembiochem; 2003 Oct; 4(10):963-71. PubMed ID: 14523912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of 2',4'-BNA/LNA-Based Oligonucleotides for Splicing Modulation In Vitro.
    Shimo T; Obika S
    Methods Mol Biol; 2018; 1828():395-411. PubMed ID: 30171556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thioamide-Bridged Nucleic Acid (thioAmNA) Containing Thymine or 2-Thiothymine: Duplex-Forming Ability, Base Discrimination, and Enzymatic Stability.
    Habuchi T; Yamaguchi T; Obika S
    Chembiochem; 2019 Apr; 20(8):1060-1067. PubMed ID: 30552742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locked nucleic acid as a novel class of therapeutic agents.
    Veedu RN; Wengel J
    RNA Biol; 2009; 6(3):321-3. PubMed ID: 19458498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative analysis of peptide-delivered antisense antibiotics using diverse nucleotide mimics.
    Ghosh C; Popella L; Dhamodharan V; Jung J; Dietzsch J; Barquist L; Höbartner C; Vogel J
    RNA; 2024 May; 30(6):624-643. PubMed ID: 38413166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides.
    Ochoa S; Milam VT
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and Evaluation of Artificial Nucleic Acid Bearing an Oxanorbornane Scaffold.
    Komine H; Mori S; Morihiro K; Ishida K; Okuda T; Kasahara Y; Aoyama H; Yamaguchi T; Obika S
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights from crystallographic studies into the structural and pairing properties of nucleic acid analogs and chemically modified DNA and RNA oligonucleotides.
    Egli M; Pallan PS
    Annu Rev Biophys Biomol Struct; 2007; 36():281-305. PubMed ID: 17288535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
    Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
    Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium-Mediated In Vitro Transfection Technique of Oligonucleotides with Broad Chemical Modification Compatibility.
    Wada F; Hori SI; Obika S; Yamamoto T
    Methods Mol Biol; 2020; 2176():141-154. PubMed ID: 32865788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical Synthesis and Biological Application of Modified Oligonucleotides.
    Glazier DA; Liao J; Roberts BL; Li X; Yang K; Stevens CM; Tang W
    Bioconjug Chem; 2020 May; 31(5):1213-1233. PubMed ID: 32227878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical etiology of nucleic acid structure: the alpha-threofuranosyl-(3'-->2') oligonucleotide system.
    Schöning K; Scholz P; Guntha S; Wu X; Krishnamurthy R; Eschenmoser A
    Science; 2000 Nov; 290(5495):1347-51. PubMed ID: 11082060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment.
    Da Ros T; Spalluto G; Prato M; Saison-Behmoaras T; Boutorine A; Cacciari B
    Curr Med Chem; 2005; 12(1):71-88. PubMed ID: 15638731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid.
    Malchère C; Verheijen J; van der Laan S; Bastide L; van Boom J; Lebleu B; Robbins I
    Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):463-8. PubMed ID: 11198930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro selection of DNA-based aptamers that exhibit RNA-like conformations using a chimeric oligonucleotide library that contains two different xeno-nucleic acids.
    Hagiwara K; Fujita H; Kasahara Y; Irisawa Y; Obika S; Kuwahara M
    Mol Biosyst; 2015 Jan; 11(1):71-6. PubMed ID: 25325213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.